Lactobacilli with superoxide dismutase-like or catalase activity are more effective in alleviating inflammation in an inflammatory bowel disease mouse model

Drug Design, Development and Therapy

Volumn 12, Issue , 2018, Pages 3221-3233

  Tomusiak Plebanek, Anna ^a   Heczko, Piotr ^a   Skowron, Beata ^a   Baranowska, Agnieszka ^a   Okoń, Krzysztof ^a   Thor, Piotr J ^a   Strus, Magdalena ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antioxidative enzymes; Inflammatory bowel diseases; Mouse model; Probiotic strains

Indexed keywords

CATALASE; SUPEROXIDE DISMUTASE; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL STRAIN; BODY MASS; BODY TEMPERATURE; CONTROLLED STUDY; DIGESTIVE SYSTEM; ENTERITIS; ENZYME ACTIVITY; FECES ANALYSIS; INFLAMMATORY BOWEL DISEASE; INTESTINE TISSUE; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS CRISPATUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS FERMENTUM; LACTOBACILLUS GASSERI; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MICROBIOLOGICAL EXAMINATION; MOUSE; NONHUMAN; ANIMAL; C57BL MOUSE; COLON; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENETICS; INFLAMMATION; ISOLATION AND PURIFICATION; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PATHOLOGY;

ANIMALS; BODY MASS INDEX; CATALASE; COLON; DISEASE MODELS, ANIMAL; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; LACTOBACILLUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SUPEROXIDE DISMUTASE;

EID: 85054898542     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S164559     Document Type: Article

References (35)

1. Scharl M, Rogler G. Inflammatory bowel disease pathogenesis: what is new? Curr Opin Gastroenterol. 2012;28(4): 301-309.
2. Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1): 91-99.
3. Strus M, Janczyk A, Gonet-Surowka A, et al. Effect of hydrogen peroxide of bacterial origin on apoptosis and necrosis of gut mucosa epithelial cells as a possible pathomechanism of inflammatory bowel disease and cancer. J Physiol Pharmacol. 2009;60(Suppl 6): 55-60.
4. Rochat T, Bermúdez-Humarán L, Gratadoux JJ, et al. Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice. Microb Cell Fact. 2007;6: 22.
5. Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol. 2003;201(1): 28-36.
6. Martín R, Miquel S, Ulmer J, et al. Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease. Microb Cell Fact. 2013;12: 71.
7. Barnese K, Gralla EB, Valentine JS, Cabelli DE. Biologically relevant mechanism for catalytic superoxide removal by simple manganese compounds. Proc Natl Acad Sci U S A. 2012;109(18): 6892-6897.
8. Miriyala S, Spasojevic I, Tovmasyan A, et al. Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta. 2012;1822(5): 794-814.
9. Kono Y, Fridovich I. Functional significance of manganese catalase in Lactobacillus plantarum. J Bacteriol. 1983;155(2): 742-746.
10. Carroll IM, Andrus JM, Bruno-Bárcena JM, et al. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol. 2007;293(4): G729-G738.
11. Han W, Mercenier A, Ait-Belgnaoui A, et al. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm Bowel Dis. 2006;12(11): 1044-1052.
12. Watterlot L, Rochat T, Sokol H, et al. Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol. 2010;144(1): 35-41.
13. Mishra V, Shah C, Mokashe N, et al. Probiotics as potential antioxidants: a systematic review. J Agric Food Chem. 2015;63(14): 3615-3626.
14. Strus M, Gosiewski T, Fyderek K, et al. A role of hydrogen peroxide producing commensal bacteria present in colon of adolescents with inflammatory bowel disease in perpetuation of the inflammatory process. J Physiol Pharmacol. 2009;60(Suppl 6): 49-54.
15. Büchler G, Wos-Oxley ML, Smoczek A, et al. Strain-specific colitis susceptibility in IL10-deficient mice depends on complex gut microbiota-host interactions. Inflamm Bowel Dis. 2012;18(5): 943-954.
16. Barnett MP, Mcnabb WC, Cookson AL, et al. Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. BMC Immunol. 2010;11: 39.
17. Hansen JJ, Holt L, Sartor RB. Gene expression patterns in experimental colitis in IL-10-deficient mice. Inflamm Bowel Dis. 2009;15(6): 890-899.
18. Maharshak N, Packey CD, Ellermann M, et al. Altered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation. Gut Microbes. 2013;4(4): 316-324.
19. Hausler WJ. Standard Methods for the Examination of Dairy Products. 13th ed. Washington, DC: American PublicHealth Association; 1972.
20. Walter J, Tannock GW, Tilsala-Timisjarvi A, et al. Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl Environ Microbiol. 2000;66(1): 297-303.
21. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med. 1999;190(7): 995-1004.
22. Jansen GJ, Mooibroek M, Idema J, Harmsen HJ, Welling GW, Degener JE. Rapid identification of bacteria in blood cultures by using fluorescently labeled oligonucleotide probes. J Clin Microbiol. 2000;38(2): 814-817.
23. Harmsen HJM, Elfferich P, Schult F. A16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microbiol Ecol Health Dis. 1999;11: 3-12.
24. Wellinghausen N, Bartel M, Essig A, Poppert S. Rapid identification of clinically relevant Enterococcus species by fluorescence in situ hybridization. J Clin Microbiol. 2007;45(10): 3424-3426.
25. Reiff C, Delday M, Rucklidge G, et al. Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(11): 1721-1736.
26. Wang LX, Liu K, Gao DW, Hao JK. Protective effects of two Lactobacillus plantarum strains in hyperlipidemic mice. World J Gastroenterol. 2013;19(20): 3150-3156.
27. Zanoni S, Pompei A, Cordisco L, et al. Growth kinetics on oligo- and polysaccharides and promising features of three antioxidative potential probiotic strains. J Appl Microbiol. 2008;105(5): 1266-1276.
28. Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging. 2007;2(2): 219-236.
29. Leblanc JG, del Carmen S, Miyoshi A, et al. Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn’s disease in mice. J Biotechnol. 2011;151(3): 287-293.
30. Valatas V, Vakas M, Kolios G. The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol. 2013;305(11): G763-G785.
31. Arthur JC, Gharaibeh RZ, Uronis JM, et al. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci Rep. 2013;3: 2868.
32. Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol. 2002;160(6): 2253-2257.
33. Huycke MM, Abrams V, Moore DR. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis. 2002;23(3): 529-536.
34. Brook I. Microbiology and management of abdominal infections. Dig Dis Sci. 2008;53(10): 2585-2591.
35. del Carmen S, de Moreno de Leblanc A, Levit R, et al. Anti-cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL-10 in a colorectal cancer mouse model. Int Immunopharmacol. 2017;42: 122-129.